0
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Comparative Pharmacokinetic Study of 5 Active Ingredients after Oral Administration of Zuogui Pill in Osteoporotic Rats with Different Syndrome Types

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Zuogui Pill is a kidney-yin-tonifying formula in traditional Chinese medicine that is widely used to manage osteoporosis with kidney-yin-deficiency in China. Herein, an efficient and accurate high-performance liquid chromatography-tandem mass spectrometry method was developed to determine the concentrations of 5 bioactive compounds in rat plasma following oral administration of Zuogui Pill. Because drug absorption and distribution differ under physiological and pathological conditions, the established method was used to quantify blood components and dynamic change in osteoporotic rats with different syndrome types. Moreover, integrated pharmacokinetic study was conducted to describe the overall pharmacokinetic characteristics of traditional Chinese medicine. The results showed that the absorption, distribution, and metabolism of Zuogui Pill varied widely under different states. The bioavailability of most active components showed significant advantages in osteoporotic rats with kidney-yin-deficiency, which corresponds to the opinion that Zuogui Pill has the effect of nourishing kidney-yin. It is hoped that this finding could interpret the pharmacodynamic substances and mechanism of Zuogui Pill in the treatment of osteoporosis with kidney-yin-deficiency.

          Related collections

          Most cited references38

          • Record: found
          • Abstract: found
          • Article: not found

          Osteoporosis

          Osteoporosis is a common systemic skeletal disorder resulting in bone fragility and increased fracture risk. However, management of osteoporosis and fracture prevention strategies are often not addressed by primary care clinicians, even in older patients with recent fractures. Evidence-based screening strategies will improve identification of patients who are most likely to benefit from drug treatment to prevent fracture. In addition, careful consideration of when pharmacotherapy should be started and choice of medication and duration of treatment will maximize the benefits of fracture prevention while minimizing potential harms of long-term drug exposure.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Hormone-replacement therapy: current thinking

            Roger Lobo (2016)
            Clinical practice regarding the use of hormone-replacement therapy (HRT) has undergone many changes since its introduction in the 1940s. Here, Roger Lobo frames the current thinking on the use of HRT in postmenopausal women, beginning with a historical perspective and then discussing how the interpretation of HRT data has changed over time.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Developmental Changes in Pharmacokinetics and Pharmacodynamics

                Bookmark

                Author and article information

                Contributors
                Journal
                Int J Anal Chem
                Int J Anal Chem
                ijac
                International Journal of Analytical Chemistry
                Hindawi
                1687-8760
                1687-8779
                2023
                25 February 2023
                : 2023
                : 1473878
                Affiliations
                1School of Pharmaceutical Sciences, Zhejiang Chinese Medical University, Hangzhou 311402, China
                2Standardization of Chinese Medicine Research Laboratory, Zhejiang Chinese Medical University, Hangzhou 311402, China
                3The First Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou 310006, China
                Author notes

                Academic Editor: Suresh Ponnayyan Sulochana

                Author information
                https://orcid.org/0000-0003-2484-8471
                https://orcid.org/0000-0003-3723-2342
                https://orcid.org/0000-0002-1330-6012
                https://orcid.org/0000-0002-0213-6484
                https://orcid.org/0000-0002-1322-4156
                Article
                10.1155/2023/1473878
                10045483
                ab3084b0-848a-46bf-9c13-e35872f33736
                Copyright © 2023 Jiawei Qiu et al.

                This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

                History
                : 28 December 2022
                : 7 February 2023
                : 15 February 2023
                Funding
                Funded by: National Natural Science Foundation of China
                Award ID: 81973868
                Award ID: 81273772
                Funded by: Natural Science Foundation of Zhejiang Province
                Award ID: LY17H270011
                Categories
                Research Article

                Analytical chemistry
                Analytical chemistry

                Comments

                Comment on this article